Arcutis logo.png
Arcutis Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
March 04, 2024 16:00 ET | Arcutis Biotherapeutics, Inc.
Arcutis today announced the closing of its previously announced underwritten public offering.
LOGO.png
Polar Power, Inc. Announces Closing of Public Offering
December 05, 2023 17:15 ET | Polar Power, Inc.
Gardena, CA, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Polar Power, Inc. (Nasdaq: POLA) (“Polar Power” or the “Company”), a technology company that designs, manufactures and sells direct current, or DC,...
Logo.png
Save Foods, Inc. Announces Closing of Public Offering
August 18, 2022 15:21 ET | Save Foods Inc
Neve Yarak, Israel, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Save Foods, Inc. (Nasdaq: SVFD) (FSE:80W), an agri-food tech company specializing in eco crop protection that helps to reduce food waste and...
Logo.jpg
Ballantyne Strong, Inc. Announces Closing of Public Offering
February 08, 2021 16:15 ET | Ballantyne Strong, Inc.
Charlotte, NC, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Ballantyne Strong, Inc. (NYSE American: BTN) (“Ballantyne Strong” or the “Company”) today announced the closing of its previously announced public...
Logo.jpg
ProPhase Labs, Inc. Announces Closing of Public Offering
January 21, 2021 16:30 ET | ProPhase Labs, Inc.
Garden City, NY, Jan. 21, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced the closing of its previously announced...
LIXTE.jpg
Lixte Biotechnology Holdings, Inc. Announces Closing of Public Offering and Uplisting to Nasdaq
December 01, 2020 12:30 ET | Lixte Biotechnology Holdings, Inc.
East Setauket, NY, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (“Lixte” or the “Company”) (Nasdaq: Common stock – LIXT; Warrants – LIXTW), a drug discovery company that uses...
Old Logo.png
Cancer Genetics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriter’s Option to Purchase Additional Shares
November 02, 2020 16:00 ET | Cancer Genetics, Inc.
Rutherford, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX) (“Cancer Genetics” or “the Company”), a leader in drug discovery and preclinical oncology and immuno-oncology...
Logo.jpg
Celsion Corporation Announces Closing of Public Offering of Common Stock
June 24, 2020 16:15 ET | Celsion CORP
Lawrenceville, NJ, June 24, 2020 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced the closing of its previously announced public offering...